Results 41 to 50 of about 29,420 (294)
Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin
Indian Journal of Ophthalmology, 2017 We report a case of Candida albicans endogenous endophthalmitis treated with intravitreal caspofungin. The patient was a known case of acute lymphoblastic leukemia on chemotherapy and presented to us with features suggestive of endogenous endophthalmitis.
Harshali Manish Yadav +3 more
doaj +1 more source
Cell wall protection by the Candida albicans class I chitin synthases [PDF]
, 2015 Open Access funded by Medical Research Council Acknowledgments We thank Kevin Mackenzie in the Microscopy and Histology Core Facility (Institute of Medical Sciences, University of Aberdeen), and Donna MacCallum for helpful statistical advice.
Anderson, Jeffrey C. +5 more
core +1 more source
Pharmacokinetics and Safety of Intravitreal Caspofungin [PDF]
Antimicrobial Agents and Chemotherapy, 2014 ABSTRACT Caspofungin exhibits potent antifungal activities against Candida and Aspergillus species. The elimination rate and retinal toxicity of caspofungin were determined in this study to assess its pharmacokinetics and safety in the treatment of fungal endophthalmitis ...
Ying-Cheng Shen +6 more
openaire +3 more sources
International Journal of Infectious Diseases, 2022 Objectives: Increased resistance of Candida species, especially Candida. glabrata is problematic. Combination antifungal therapies were studied to solve the problem.
Qianting Yang +6 more
doaj
Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus [PDF]
, 2017 This work was supported by Medical Mycology Section, Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Seyedmousavi, Seyedmojtaba +3 more
core +1 more source
Frontiers in Pharmacology, 2020 Caspofungin is the first echinocandin antifungal agent that licented for pediatric use in invasive candidiasis and aspergillosis. In this study, we evaluated the population pharmacokinetics of caspofungin and investigate appropriate dosing optimization ...
Chang-He Niu +7 more
doaj +1 more source
Susceptibility Pattern of Caspofungin-Coated Gold Nanoparticles Against Clinically Important Candida Species [PDF]
Advanced Pharmaceutical Bulletin, 2021 Purpose: The present study was performed to examine whether caspofungin-coated gold nanoparticles (CAS-AuNPs) may offer the right platform for sensitivity induction in resistant isolates.
Zahra Salehi +5 more
doaj +1 more source
Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence. [PDF]
, 2016 Aspergillus spp. are a group of filamentous molds that were first described due to a perceived similarity to an aspergillum, or liturgical device used to sprinkle holy water, when viewed under a microscope.
Stewart, Ethan R, Thompson, George R
core +3 more sources
Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]
, 2017 The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew +6 more
core +3 more sources
Caspofungin Induced Cell Wall Changes of Candida Species Influences Macrophage Interactions
Frontiers in Cellular and Infection Microbiology, 2020 Candida species are known to differ in their ability to cause infection and have been shown to display varied susceptibilities to antifungal drugs. Treatment with the echinocandin, caspofungin, leads to compensatory alterations in the fungal cell wall ...
L. Walker, C. Munro
semanticscholar +1 more source